Forte Biosciences, Inc. — Director's Dealing 2019

Oct 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tocagen Inc (TOCA)
CIK: 0001419041
Period of Report: 2019-10-04

Reporting Person: BERGER FRANKLIN M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-04	Stock Option (right to buy)	$0.6391	A	7500	Acquired	2029-10-03	Common Stock (7500)	Direct

Footnotes

F1: The shares vest in a series of twelve (12) successive equal monthly installments measured from October 3, 2019.